Skip to content

Analgesic Mechanisms of Percutaneous Electrolysis

Neurophysiological Effects of Percutaneous Electrolysis Related to Endogenous Pain Modulation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05097937
Enrollment
54
Registered
2021-10-28
Start date
2021-11-22
Completion date
2022-02-11
Last updated
2022-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Endogenous Analgesia System, Pain, Pain Modulation, Percutaneous Electrolysis

Brief summary

Percutaneous electrolysis is based on the application of a galvanic current through an acupuncture needle. The underlying mechanisms that explain the efficacy of this technique are not completely well understood. The objective is to delve into the neurophysiological analgesic effects of percutaneous electrolysis. Participants will be assigned to one of three intervention groups. The analgesic effects of the technique will be evaluated by means of variables related to endogenous pain modulation.

Interventions

OTHERSham intervention

The needle will be inserted into the right common extensor tendon of the epicondyle for 90 seconds without galvanic current.

A single impact of galvanic current will be applied in the common extensor tendon of the epicondyle (right side) with an intensity of 0.3 mA for 90 seconds.

Three impacts of galvanic current will be applied in the common extensor tendon of the epicondyle (right side) with an intensity of 3 mA and a duration of 3 seconds each.

Sponsors

University of Salamanca
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Asymptomatic subjects * Signature of the informed consent

Exclusion criteria

* Fear of needles * Any pathology or process that causes pain * Neurological, rheumatologic, cardiovascular or metabolic diseases * Cutaneous alterations and cognitive or sensitivity disorders * Pregnancy * Recent intake of alcohol or caffeine * Vigorous physical activity on the day of testing

Design outcomes

Primary

MeasureTime frameDescription
Changes from baseline in Pressure Pain Thresholds (PPT)Baseline and immediately after the interventionPPTs will be measure by algometry in the common extensor tendon of the epicondyle, bicipital groove and tibialis anterior muscle (all of the right side).

Secondary

MeasureTime frameDescription
Changes from baseline in Conditioned Pain Modulation (CPM)Baseline and immediately after the interventionCPM will be assess by upper extremity submaximal effort tourniquet test with algometric measures in the common extensor tendon of the epicondyle, bicipital groove and tibialis anterior muscle (all of the right side).
Changes from baseline in Temporal Summation (TS)Baseline and immediately after the interventionAssessed by Verbal Numeric Rating Scale (11-point). 10 consecutive pressures will be applied in the three previous locations (epicondyle, bicipital groove and tibialis anterior) with the algometer at the intensity of the pressure pain threshold

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026